BioSignal Nexus™ maps latent scientific conviction and clinical development velocities across public biotechnology markets.
We crawl, parse, and verify records from official regulatory and scientific databases including SEC EDGAR (13F filing registrations), ClinicalTrials.gov (Phase updates and indications), USPTO (patent assignments), and PubMed (citation acceleration velocities).
All scores (such as the Momentum Index score) represent model-generated statistical outputs weighing historical class success metrics, publication frequencies, and comparative study cohorts. They are not direct predictions of clinical success or investment outcomes.